Objective: The treatment of infant renal stones is still a huge challenge to the urologist. The present study aimed to evaluate the safety and efficiency of the minimally invasive percutaneous nephrolithotomy (MPCNL) method as a treatment for infant renal stones, and also to analyze the specific techniques and related complications of the procedure. Patients and Methods: From January 2008 to December 2012, 234 cases (72 girls and 162 boys, mean age 15.8 months, range 5-36 months) aged under 3 years and treated with MPCNL for renal stones were analyzed retrospectively. 125 cases were younger than 12 months, 67 cases were between 13 and 24 months and 42 cases between 25 and 36 months. The indications for MPCNL were (1) stone over 1 cm2, (2) hydronephrosis and (3) recurrent urinary tract infection. An initial percutaneous access to the targeted renal calyx was obtained through an ultrasound-guided peripheral calyceal puncture. Stones were fragmented by a holmium laser with a pediatric nephroscope via 14-F tract. Results: All the procedures were performed by single tract, and totally 247 tracts were established, including 245 14-F tracts, 1 16-F tract and 1 12-F tract, respectively. The stones were located in the left kidney (n = 91), right kidney (n = 105) and in both kidneys (n = 28), respectively. Regarding the puncture point, in 228 cases it was in the 12th subcostal space and in 19 cases in the 11th intercostal space. The distribution of target puncture calyx and the subsequent residual calculi were as follows: 39 cases in the upper calyx with 2 cases of stone residual, 148 in the middle calyx with 3 stone residuals, and 60 in the lower calyx with 2 stone residuals, respectively. As a result, completely stone-free state was achieved in 240 kidney units (97.2%). The mean operating time was 32.5 min. None of the patients required blood transfusion and no septic shock occurred after operation. A large quantity of washing fluid was infiltrated into the abdominal cavity in 3 cases. Conclusion: Using a single tract ≤14 F, MPCNL is a safe and effective procedure in the management of renal stones in infant less than 3 years old.

Keywords:
Infant, Kidney calculi, Percutaneous nephrolithotomy
1.
Frattini A, Ferretti S, Salvaggio A: Percutaneous nephrolithotripsy (PCNL) in children: experience of Parma. Arch Ital Urol Androl 2010;82:51-52.
2.
Zeng G, Zhao Z, Zhao Z, Yuan J, Wu W, Zhong W: Percutaneous nephrolithotomy in infants: evaluation of a single-center experience. Urology 2012;80:408-411.
3.
Guven S, Istanbulluoglu O, Ozturk A, Ozturk B, Piskin M, Cicek T, Kilinc M, Ozkardes H, Arslan M: Percutaneous nephrolithotomy is highly efficient and safe in infants and children under 3 years of age. Urol Int 2010;85:455-460.
4.
Guven S, Istanbulluoglu O, Gul U, Ozturk A, Celik H, Aygün C, Ozdemir U, Ozturk B, Ozkardes H, Kilinc M: Successful percutaneous nephrolithotomy in children: multicenter study on current status of its use, efficacy and complications using Clavien classification. J Urol 2011;185:1419-1424.
5.
Woodside JR, Stevens GF, Stark GL, Borden TA, Ball WS: Percutaneous stone removal in children. J Urol 1985;134:1166-1167.
6.
Jackman SV, Hedican SP, Peters CA, Docimo SG: Percutaneous nephrolithotomy in infants and preschool age children: experience with a new technique. Urology 1998;52:697-701.
7.
El-Nahas AR, Shokeir AA, El-Kenawy MR, Shoma AM, Eraky I, El-Assmy AM, Ghaly AM, El-Kappany HA: Safety and efficacy of supracostal percutaneous nephrolithotomy in pediatric patients. J Urol 2008;180:676-680.
8.
Bhageria A, Nayak B, Seth A, Dogra PN, Kumar R: Paediatric percutaneous nephrolithotomy: single-centre 10-year experience. J Pediatr Urol 2013;9:472-475.
9.
Atallah N, Slaba S, Karam R, Salem C, Merhej S: Complications of percutaneous nephrostomy. Apropos of 481 procedures: the value of puncture of the median calices (in French). J Med Liban 1999;47:92-94.
10.
Anand A, Kumar R, Dogra PN, Seth A, Gupta NP: Safety and efficacy of a superior caliceal puncture in pediatric percutaneous nephrolithotomy. J Endourol 2010;24:1725-1728.
11.
Kapoor R, Solanki F, Singhania P, Andankar M, Pathak HR: Safety and efficacy of percutaneous nephrolithotomy in the pediatric population. J Endourol 2008;22:637-640.
12.
Etemadian M, Maghsoudi R, Shadpour P, Mokhtari MR, Rezaeimehr B, Shati M: Pediatric percutaneous nephrolithotomy using adult sized instruments. Urol J 2012;9:465-471.
13.
Manohar T, Ganpule AP, Shrivastav P, Desai M: Percutaneous nephrolithotomy for complex caliceal calculi and staghorn stones in children less than 5 years of age. J Endourol 2006;20:547-551.
14.
Bilen CY, Koçak B, Kitirci G, Ozkaya O, Sarikaya S: Percutaneous nephrolithotomy in children: lessons learned in 5 years at a single institution. J Urol 2007;177:1867-1871.
15.
VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, Trachtman H: Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 2007;177:2300-2305.
16.
Alpay H, Ozen A, Gokce I, Biyikli N: Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol 2009;24:2203-2209.
17.
Sternberg K, Greenfield SP, Williot P, Wan J: Pediatric stone disease: an evolving experience. J Urol 2005;174:1711-1714.
18.
Rizvi SA, Naqvi SA, Hussain Z, Hashmi A, Hussain M, Zafar MN, Sultan S, Mehdi H: Pediatric urolithiasis: developing nation perspectives. J Urol 2002;168:1522-1525.
19.
Daudon M, Doré JC, Jungers P, Lacour B: Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 2004;32:241-247.
20.
Kamoun A, Daudon M, Abdelmoula J, Hamzaoui M, Chaouachi B, Houissa T, Zghal A, Ben Ammar S, Belkahia C, Lakhoua R: Urolithiasis in Tunisian children: a study of 120 cases based on stone composition. Pediatr Nephrol 1999;13:920-926.
21.
Desai MR, Kukreja RA, Patel SH, Bapat SD: Percutaneous nephrolithotomy for complex pediatric renal calculus disease. J Endourol 2004;18:23-27.
22.
Salah MA, Tóth C, Khan AM, Holman E: Percutaneous nephrolithotomy in children: experience with 138 cases in a developing country. World J Urol 2004;22:277-280.
23.
Salah MA, Tállai B, Holman E, Khan MA, Tóth G, Tóth C: Simultaneous bilateral percutaneous nephrolithotomy in children. BJU Int 2005,95:137-139.
24.
Boormans JL, Scheepe JR, Verkoelen CF, Verhagen PC: Percutaneous nephrolithotomy for treating renal calculi in children. BJU Int 2005;95:631-634.
25.
Guven S, Frattini A, Onal B, Desai M, Montanari E, Kums J, Garofalo M, de la Rosette J; CROES PCNL Study Group: Percutaneous nephrolithotomy in children in different age groups: data from the Clinical Research Office of the Endourological Society (CROES) Percutaneous Nephrolithotomy Global Study. BJU Int 2013;111:148-156.
26.
Gregory JG, Schoenberg HW, Sana U, Thompson J: Neonatal urinary ascites. Urology 1975;5:394-396.
27.
Kay R, Brereton RJ, Johnson JH: Urinary ascites in the newborn. Br J Urol 1980;52:451-454.
28.
Barry JM, Anderson JM, Hodges CV: The subcapsular C sign: a rare radiographic finding associated with neonatal urinary ascites. J Urol 1974;112:836-839.
29.
Dockray KT: Preferred treatment for urinary ascites in newborns: a report of the eighteenth survivor and a review of therapy for those living and dead. J Urol 1974;112:840-841.
30.
Cass AS, Khan AU, Smith S, Godec C: Neonatal perirenal urinary extravasation with posterior urethral valves. Urology 1981;18:258-261.
31.
Lord JM: Foetal ascites. Arch Dis Child 1953;28:398-403.
32.
Wadhwa P, Aron M, Bal CS, Dhanpatty B, Gupta NP: Critical prospective appraisal of renal morphology and function in children undergoing shockwave lithotripsy and percutaneous nephrolithotomy. J Endourol 2007;21:961-966.
33.
Mahmud M, Zaidi Z: Percutaneous nephrolithotomy in children before school age: experience of a Pakistani centre. BJU Int 2004;94:1352-1354.
34.
Dawaba MS, Shokeir AA, Hafez A, Shoma AM, El-Sherbiny MT, Mokhtar A, Eraky I, El-Kenawy M, El-Kappany HA: Percutaneous nephrolithotomy in children: early and late anatomical and functional results. J Urol 2004;172:1078-1081.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.